Tyler Tarr




Dr. Stephen Meriney


Utilizing presynaptic structure-function properties to inform the design of novel therapies for neuromuscular diseaseĀ 

Prior Degree

BS, University of Pittsburgh (2014)


Tarr, T.B., Malick, W., Liang, M., Valdomir, G., Frasso, M., Lacomis, D., Reddel, S.W., Garcia-Ocano, A., Wipf, P., Meriney, S.D. Evaluation of a novel calcium channel agonist for therapeutic potential in Lambert-Eaton Myasthenic Syndrome. J. Neuroscience 33: 10559-10567, 2013.

Tarr, T.B., Dittrich, M. and Meriney, S.D. Are Unreliable Release Mechanisms Conserved from NMJ to CNS? Trends Neurosci. 36: 14-22, 2013.

Liang, M., Tarr, T.B., Bravo-Altamirano, K., Valdomir, G., Rensch, G., Swanson, L., DeStefino, N.R., Mazzarisi, C.M., Olszewski, R.A., Wilson, G.M., Meriney, S.D. and Wipf, P. Synthesis and Biological Evaluation of a Selective N- and P/Q-Type Calcium Channel Agonist. ACS Med. Chem. Lett. 3: 985-990, 2012

Tarr, T.B., Valdomir, G., Liang, M., Wipf, P. and Meriney, S.D. New calcium channel agonists as potential therapeutics in LEMS and other neuromuscular diseases. Ann. N.Y. Acad. Sci. 1275: 85-91, 2012.